MedPath

Podcasting HIV Prevention Within African American Communities

Not Applicable
Completed
Conditions
HIV Prevention
Registration Number
NCT05365958
Lead Sponsor
University of Houston
Brief Summary

Given the continued impact of HIV among African Americans, there is still an urgent need to expand prevention efforts and HIV testing in African American communities. Heterosexual individuals may acquire and spread infection directly through heterosexual contact, bi-sexual sexual contact, and/or indirectly through homosexual sexual contact. Evidence-based interventions (EBIs) have been shown to increase consistent condom use, decrease sexual partners, and increase HIV testing; however, traditionally-implemented EBIs may not be accessible to communities given the resources and expertise needed to implement them. This project seeks to: 1) assess feasibility for the development of two theory- based, video podcast-delivered, HIV prevention interventions for self-identified heterosexual African American males and females; and 2) evaluate their feasibility \& effectiveness (pilot). The investigators will develop the two (male and female) video podcasts that maintain the theoretical integrity of two established Centers for Disease Control evidence-based behavioral HIV prevention interventions. The assessment phase will consist of leveraging African American community stakeholders and experts in the development of the podcast content. The effectiveness phase will consist of broadcasting the podcasts for participants and evaluating psychosocial factors related to HIV prevention at 1 and 3 month follow-ups. This intervention is the first of its kind and has the potential to increase HIV protective behaviors in this hard-to-reach and medically underserved population. The resulting interventions are expected to be easily disseminated throughout the African American communities, with the potential to reduce HIV- related disparities within this population. This study will impact and advance the field by demonstrating feasibility and effectiveness for a novel mode of intervention engagement within HIV prevention science, serve as valuable preliminary data for a larger R01 trial, and foster HIV prevention awareness within the African American community.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • self-identify as African American
  • speak and read English
  • 18 years old or older
  • not currently or previously diagnosed with HIV
Exclusion Criteria

• currently or previously diagnosed with HIV

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Condom Use Self-Efficacy (From Baseline to 1 Month Follow-up)To be measured immediately before film viewing (baseline) and at 1 month follow-up

A change between baseline and 1 month regarding condom use self-efficacy scale scores.

Results reflect mean difference and mean standard deviation in a repeated measures t-test analysis.

The 5-item subscale scores were summed and averaged across participants, yielding an average scale score range of 1-5; higher scale values indicating greater self-efficacy to use condoms.

Scale scores were assessed for participants immediately before the intervention and 1 month after the intervention. The method used was repeated measures t-test. The analysis reports the group average scale score and standard deviation for participants at 1 month followup.

Condom Use Intention Item (1 Month Followup)To be measured 1 month after film viewing

Uses the condom use intention item (average) of the measure. "I plan to use condoms the next time I have sex." Item was scaled from 1-strongly disagree to 5-strongly agree. Higher scale scores indicate greater intention to use a condom during intercourse; Lower scale scores indicate lesser intention to use a condom during intercourse.The item was summed across participants, separately for baseline and 1 month followup to yield a pretest group mean average (baseline) and a 1 month followup group mean average. The method used was repeated measures t-test, which tested group mean differences between baseline (pretest average) and 1 month followup average. The analysis reports the group average scale score and standard deviation for participants at 1 month followup.

HIV Test Intentions (Single Item)1 month after film viewing

Uses a single item "I intend to obtain an HIV test within the next 2 months?" Item was scaled from 1-strongly disagree to 5-strongly agree. Higher scale scores indicate greater intention to acquire an HIV test; Lower scale scores indicate less intention to acquire an HIV test.The item scores were summed across participants, separately for baseline and 1 month followup to yield a pretest group mean average (baseline) and a 1 month followup group mean average. The method used was repeated measures t-test, which tested group mean differences between baseline (pretest average) and 1 month followup average. The analysis reports the group average scale score and standard deviation for participants at 1 month followup.

Number of Participants With Who Have Obtained a HIV Test at 1 Month After Film ViewingTo be measured 1 month after film viewing

To observe whether the film viewing influenced behavior of obtaining a HIV test at 1 month followup. Outcome was measured with a single item: "Have you obtained an HIV test (-you will not be required to disclose the results of this test)?" Item was scaled on a nominal scale of measurement as (0) No, (1) Maybe, and (2) Yes. A count of "Yes" (converted to percentage) was used as the primary outcome.

Number of Participants With Who Have Obtained a HIV Test at 3 Months After Film ViewingTo be measured 3 months after film viewing

To observe whether the film viewing influenced behavior of obtaining a HIV test at 3 month followup. Outcome was measured with a single item: "Have you obtained an HIV test (-you will not be required to disclose the results of this test)?" Item was scaled on a nominal scale of measurement as (0) No, (1) Maybe, and (2) Yes. A count of "Yes" (converted to percentage) was used as the primary outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jacob's Home for Men

🇺🇸

Houston, Texas, United States

Jacob's Home for Men
🇺🇸Houston, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.